Fulton Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.36M | Buy |
6,697
+95
| +1% | +$45.6K | 0.1% | 138 |
|
|
2026
Q1 | $3.25M | Sell |
6,602
-127
| -2% | -$68.9K | 0.11% | 130 |
|
|
2025
Q4 | $3.9M | Sell |
6,729
-35
| -0.5% | -$19.8K | 0.13% | 103 |
|
|
2025
Q3 | $3.28M | Sell |
6,764
-89
| -1% | -$41.4K | 0.11% | 119 |
|
|
2025
Q2 | $2.78M | Sell |
6,853
-411
| -6% | -$172K | 0.1% | 138 |
|
|
2025
Q1 | $3.61M | Sell |
7,264
-897
| -11% | -$486K | 0.15% | 105 |
|
|
2024
Q4 | $4.25M | Buy |
8,161
+288
| +4% | +$158K | 0.16% | 91 |
|
|
2024
Q3 | $4.87M | Sell |
7,873
-241
| -3% | -$143K | 0.19% | 89 |
|
|
2024
Q2 | $4.49M | Buy |
8,114
+479
| +6% | +$274K | 0.18% | 90 |
|
|
2024
Q1 | $4.44M | Sell |
7,635
-61
| -0.8% | -$34.2K | 0.18% | 88 |
|
|
2023
Q4 | $4.08M | Buy |
7,696
+208
| +3% | +$101K | 0.18% | 91 |
|
|
2023
Q3 | $3.79M | Sell |
7,488
-73
| -1% | -$38.9K | 0.19% | 89 |
|
|
2023
Q2 | $3.94M | Sell |
7,561
-225
| -3% | -$121K | 0.19% | 91 |
|
|
2023
Q1 | $4.49M | Buy |
7,786
+20
| +0.3% | +$11.3K | 0.24% | 74 |
|
|
2022
Q4 | $4.28M | Buy |
7,766
+391
| +5% | +$207K | 0.24% | 77 |
|
|
2022
Q3 | $3.74M | Buy |
7,375
+432
| +6% | +$242K | 0.22% | 76 |
|
|
2022
Q2 | $3.77M | Buy |
6,943
+166
| +2% | +$91.4K | 0.21% | 81 |
|
|
2022
Q1 | $4M | Buy |
6,777
+799
| +13% | +$459K | 0.19% | 91 |
|
|
2021
Q4 | $3.99M | Buy |
5,978
+208
| +4% | +$130K | 0.18% | 99 |
|
|
2021
Q3 | $3.3M | Buy |
5,770
+1,213
| +27% | +$666K | 0.15% | 100 |
|
|
2021
Q2 | $2.3M | Buy |
4,557
+146
| +3% | +$68.9K | 0.11% | 135 |
|
|
2021
Q1 | $2.01M | Sell |
4,411
-132
| -3% | -$63K | 0.1% | 148 |
|
|
2020
Q4 | $2.12M | Buy |
4,543
+162
| +4% | +$76K | 0.11% | 130 |
|
|
2020
Q3 | $1.94M | Sell |
4,381
-632
| -13% | -$261K | 0.12% | 130 |
|
|
2020
Q2 | $1.82M | Sell |
5,013
-112
| -2% | -$37.5K | 0.12% | 129 |
|
|
2020
Q1 | $1.45M | Buy |
5,125
+371
| +8% | +$117K | 0.12% | 142 |
|
|
2019
Q4 | $1.54M | Buy |
4,754
+203
| +4% | +$61.6K | 0.1% | 165 |
|
|
2019
Q3 | $1.32M | Buy |
4,551
+128
| +3% | +$36.7K | 0.09% | 167 |
|
|
2019
Q2 | $1.3M | Buy |
4,423
+110
| +3% | +$30.3K | 0.09% | 170 |
|
|
2019
Q1 | $1.18M | Buy |
4,313
+128
| +3% | +$31.9K | 0.08% | 172 |
|
|
2018
Q4 | $937K | Buy |
4,185
+145
| +4% | +$34K | 0.07% | 183 |
|
|
2018
Q3 | $986K | Buy |
4,040
+414
| +11% | +$95.2K | 0.06% | 200 |
|
|
2018
Q2 | $751K | Buy |
3,626
+152
| +4% | +$32.3K | 0.05% | 221 |
|
|
2018
Q1 | $717K | Buy |
3,474
+1,061
| +44% | +$223K | 0.05% | 216 |
|
|
2017
Q4 | $458K | Buy |
2,413
+209
| +9% | +$40K | 0.03% | 293 |
|
|
2017
Q3 | $417K | Buy |
2,204
+234
| +12% | +$42.4K | 0.03% | 309 |
|
|
2017
Q2 | $344K | Buy |
+1,970
| New | +$331K | 0.03% | 333 |
|
Other funds holding TMO
Fulton Bank's TMO Position: Q2 2026 in Review
Fulton Bank increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, buying an estimated $45.6K and bringing the position to 6,697 shares worth $3.36M. The position accounts for 0.1% of the portfolio, ranked #138.
Fulton Bank first reported a position in TMO in Q2 2017 and has held it in 37 quarters since. The position peaked at $4.87M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Fulton Bank held 6,697 shares of Thermo Fisher Scientific worth $3.36M as of Q2 2026.
- Fulton Bank bought 95 Thermo Fisher Scientific shares in Q2 2026, an estimated $45.6K.
- Thermo Fisher Scientific made up 0.1% of Fulton Bank's portfolio in Q2 2026, its #138 holding.
- Fulton Bank first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 37 quarters since.
- Fulton Bank's Thermo Fisher Scientific position peaked at $4.87M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.